Today: 9 June 2026
Gold price tumbles again on CME margin hike; traders brace for U.S. payrolls
2 February 2026
2 mins read

Gold price tumbles again on CME margin hike; traders brace for U.S. payrolls

New York, Feb 2, 2026, 10:11 EST — Regular session

Gold prices plunged further on Monday, with spot bullion falling 3% to $4,718.35 an ounce by 9:10 a.m. ET, after an earlier drop of nearly 10%. U.S. April gold futures held steady around $4,740.90, leaving the metal about $900 below its Jan. 29 record high of $5,594.82 following a steep 9.8% fall on Friday. The selloff accelerated after CME Group raised margin requirements for precious-metals futures and the dollar strengthened on news that President Donald Trump nominated Kevin Warsh to head the Federal Reserve.

This move is significant because margin hikes require traders to put up more cash to maintain futures positions. When markets move quickly, that often leads to forced selling as leveraged bets are trimmed, even if the bigger picture remains intact.

On Jan. 30, CME announced margin increases for Comex futures. Margins on 100-ounce gold contracts will jump to 8% from 6% for standard accounts, and to 8.8% from 6.6% for those deemed heightened risk. Silver futures margins will climb to 15% from 11%, or 16.5% from 12.1% for heightened-risk accounts. These changes take effect after Monday’s close.

Spot silver dropped 3.3% to $81.75 an ounce, now about 32% below last week’s peak. Platinum edged down 1.4% to $2,132.55, while palladium fell 2.7% to $1,743.93. John Meyer, analyst at SP Angel, described the market as “on a rollercoaster ride,” highlighting outflows from gold-backed ETFs that trade like stocks. Deutsche Bank’s Michael Hsueh said the outlook doesn’t suggest a sustained rebound, with investors still willing to pay premiums for potential gains. MarketScreener

The shock has spread through commodities and risk assets as investors digest what Warsh’s Fed pick could signal. Vivek Dhar at Commonwealth Bank of Australia called the market reaction “more hawkish,” while Tony Sycamore at IG compared the scale of the sell-off to the “dark days of the 2008 global financial crisis.” A hawkish central bank typically favors higher rates to fight inflation, which usually boosts the dollar and makes holding non-yielding gold more expensive. Reuters

Warsh, a former Fed governor, is slated to take over from Chair Jerome Powell when his term expires in May, though his nomination will face a tough Senate confirmation. Known previously as an inflation hawk, Warsh now supports rate cuts and shrinking the Fed’s balance sheet. The central bank cut rates three times in 2025, bringing them to 3.50%-3.75%. Markets don’t see another cut coming until June, according to Reuters.

Gold doesn’t yield interest. If traders expect rates to remain elevated or the dollar to keep climbing, the metal’s allure can fade fast, especially following an extended rally.

Some banks continue to back the bull case. J.P. Morgan said it remains “firmly bullishly convicted” on gold over the medium term, targeting $6,300 an ounce by the end of 2026, driven by ongoing buying from central banks and investors. Deutsche Bank stuck to its $6,000 forecast. Reuters

There is a downside risk that doesn’t require fresh negative headlines. Should the dollar maintain its strength and margin calls pile up following Monday’s close, traders warn that forced selling could continue, pushing prices down amid thin liquidity.

Attention is turning to Friday’s U.S. jobs report, a key data point that could jolt Treasury yields and reshape expectations for rate cuts in a single release. The Bureau of Labor Statistics is set to publish the January Employment Situation report on Feb. 6 at 8:30 a.m. ET.

Stock Market Today

  • Soybean Prices Dip Amid Export Sales and Crop Progress Reports
    June 9, 2026, 9:20 AM EDT. Soybeans experienced modest declines on Monday, with futures dropping up to 5¾ cents and the national average cash price falling to $10.57 1/2 per bushel. The USDA reported a private sale of 264,000 metric tons for the 2026/27 marketing year. Weekly export shipments fell 21.2%, totaling 398,186 MT, led by Egypt, China, and Mexico. Crop progress shows 92% planted and emergence ahead of schedule, though crop conditions slipped slightly. Marketing year exports remain 20.3% below last year, reflecting pressure on prices. Soymeal futures declined 20 cents, and soy oil futures showed mixed moves. These indicators suggest cautious market sentiment amid ongoing supply and demand factors shaping the soybean market.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Apple stock price today: AAPL ticks up on India tax win, analyst call — what investors watch next
Previous Story

Apple stock price today: AAPL ticks up on India tax win, analyst call — what investors watch next

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next
Next Story

Freeport-McMoRan stock steadies after wild swing as copper tumbles — what to watch next

Go toTop